▲ Peaking
Business
Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
Roche and Genentech have entered a multi-billion dollar licensing agreement with Hanmi Pharm for a novel, muscle-sparing obesity therapy.